Mycophenolate Mofetil (Akorn, Inc.)
Welcome to the PulseAid listing for the Mycophenolate Mofetil drug offered from Akorn, Inc.. This Antimetabolite Immunosuppressant [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Akorn, Inc. |
NON-PROPRIETARY NAME: | Mycophenolate Mofetil |
SUBSTANCE NAME: | MYCOPHENOLATE MOFETIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antimetabolite Immunosuppressant [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-02-28 |
END MARKETING DATE: | 0000-00-00 |
Mycophenolate Mofetil HUMAN PRESCRIPTION DRUG Details:
Item Description | Mycophenolate Mofetil from Akorn, Inc. |
LABELER NAME: | Akorn, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500(mg/20mL) |
START MARKETING DATE: | 2017-02-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 17478-422_490fa8f3-3b59-4277-9ce6-78441f2debb1 |
PRODUCT NDC: | 17478-422 |
APPLICATION NUMBER: | ANDA204043 |
Other MYCOPHENOLATE MOFETIL Pharmaceutical Manufacturers / Labelers: